Related Experiment Video
Updated: Jun 3, 2025
Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
State of the Art in Left Atrial Appendage Occlusion
Jalaj Garg1, Rajesh Kabra2, Rakesh Gopinathannair2
1Division of Cardiology, Cardiac Arrhythmia Service, Loma Linda University Health, Loma Linda, California, USA.
Insights
Left atrial appendage occlusion (LAAO) offers stroke prevention for atrial fibrillation patients. This review covers LAAO device advancements, patient selection, and complication management for optimal clinical application.
Area of Science:
- Cardiology
- Medical Devices
- Interventional Procedures
Background:
- Left atrial appendage occlusion (LAAO) is crucial for preventing strokes in nonvalvular atrial fibrillation.
- Significant advancements in LAAO devices (percutaneous and surgical) have occurred over 20 years.
- Key clinical questions remain regarding patient selection, optimal approaches, and complication management.
Purpose of the Study:
- To review fundamental concepts of the left atrial appendage.
- To discuss current management strategies for LAAO.
- To address unanswered questions in LAAO therapy.
Main Methods:
- Literature review of advancements in LAAO devices and techniques.
- Analysis of current clinical needs and challenges in LAAO.
- Synthesis of information on patient selection, procedural approaches, and complication management.
Main Results:
- LAAO is an established therapy with evolving device technology.
- Optimal patient selection and procedural choice require further clarification.
- Management of complications like pericardial effusion, device-related thrombus, and leaks is critical.
Conclusions:
- LAAO is a vital stroke prevention strategy in atrial fibrillation.
- Further research is needed to optimize LAAO patient selection and device choice.
- Effective management of LAAO-related complications is essential for patient outcomes.
Abstract:
Left atrial appendage occlusion (LAAO) has become an important therapeutic target for stroke prevention in patients with nonvalvular atrial fibrillation. Over the past 2 decades, several advancements in LAAO devices (percutaneous and surgical) have been made for stroke prevention and arrhythmia therapy. However, there are several unanswered questions regarding optimal patient selection, the preferred LAAO approach and device, the management of periprocedural and postprocedural complications, including pericardial effusion, device-related thrombus, and device leaks. This review focuses on fundamental foundational concepts in various aspects of the left atrial appendage and management strategies as they relate to current clinical needs.
